- Research works
- 25 ▼ 25% vs 2013–17
- Citations
- 193 7.8 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 52% world 28%
Not ranked overall: Royal London Group (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemical Engineering, 8.2×. Every wedge is a field page.
Which keywords describe research at Royal London Group (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Complications, Clinical Trials, Chemotherapy, Inflammation, Proton Pump Inhibitors, Metastasis and Genomic Analysis.
- Treatment
- Diagnosis
- Gastroesophageal Reflux Disease
- Biomarkers
- Genomic Analysis
- Proton Pump Inhibitors
- Clinical Trials
- Inflammation
- Epidemiology
- Complications
- Chemotherapy
- Metastasis
- Management
- Esophageal Motility Disorders
- Cytoreductive Surgery
- Ovarian Cancer
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Epidemiology4▲ 3.8×18 topics
- Inflammation2▲ 3.7×11 topics
- Complications2▲ 13×4 topics
- Clinical Trials2▲ 10×5 topics
- Chemotherapy2▲ 8.7×5 topics
- Proton Pump Inhibitors1▲ 69×2 topics
- Metastasis1▲ 16×4 topics
- Genomic Analysis1▲ 16×2 topics
- Management1▲ 6.5×6 topics
- Biomarkers1▲ 7.3×3 topics
- Esophageal Motility Disorders1▲ 124×1 topic
- Gastroesophageal Reflux Disease1▲ 124×1 topic
- Cytoreductive Surgery1▲ 62×1 topic
- Diagnosis1▲ 4.1×5 topics
- Ovarian Cancer1▲ 44×1 topic
- Treatment1▲ 3.2×4 topics
Which research topics does Royal London Group (United Kingdom) publish most on?
By volume in 2022–2025: Pharmacology and Obesity Treatment, Diabetes Treatment and Management, Gallbladder and Bile Duct Disorders and Esophageal and GI Pathology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pharmacology and Obesity Treatment Pharmacology 0 works
- 2 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 0 works
- 3 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works
- 4 Esophageal and GI Pathology Surgery 0 works
- 5 Pancreatic and Hepatic Oncology Research Oncology 0 works
- 6 Diet and metabolism studies Physiology 0 works
- 7 Neurosurgical Procedures and Complications Neurology 0 works
- 8 Acute Myocardial Infarction Research Cardiology and Cardiovascular Medicine 0 works
- 9 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 0 works
- 10 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Royal London Group (United Kingdom)'s research output changed?
Output in 2018–2022 was 25% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.